Evogene (EVGN) Tops Q1 EPS by 2c

Evogene (NASDAQ: EVGN) reported Q1 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $3.38 million.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance